F M Quitkin

2.6k total citations
43 papers, 2.0k citations indexed

About

F M Quitkin is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, F M Quitkin has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 17 papers in Psychiatry and Mental health and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in F M Quitkin's work include Treatment of Major Depression (21 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers) and Electroconvulsive Therapy Studies (8 papers). F M Quitkin is often cited by papers focused on Treatment of Major Depression (21 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers) and Electroconvulsive Therapy Studies (8 papers). F M Quitkin collaborates with scholars based in United States and Canada. F M Quitkin's co-authors include Patrick J. McGrath, Edward V. Nunes, Patrick J. McGrath, Jonathan W. Stewart, Katja Ocepek‐Welikson, Judith G. Rabkin, E Tricamo, Wilma Harrison, Gerard E. Bruder and Craig E. Tenke and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Abnormal Psychology.

In The Last Decade

F M Quitkin

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F M Quitkin United States 24 935 814 565 452 313 43 2.0k
Duane G. Spiker United States 28 689 0.7× 890 1.1× 809 1.4× 964 2.1× 336 1.1× 53 2.6k
Michael Philipp Germany 22 654 0.7× 845 1.0× 664 1.2× 335 0.7× 495 1.6× 82 2.2k
J. Mendlewicz Belgium 25 452 0.5× 562 0.7× 603 1.1× 485 1.1× 448 1.4× 69 2.4k
Eric D. Peselow United States 38 712 0.8× 1.5k 1.8× 780 1.4× 706 1.6× 838 2.7× 103 3.5k
Sanjay Dubé United States 20 847 0.9× 1.4k 1.7× 362 0.6× 361 0.8× 242 0.8× 48 2.6k
M E Thase United States 14 614 0.7× 592 0.7× 378 0.7× 241 0.5× 397 1.3× 18 1.5k
J. E. Christie United Kingdom 20 422 0.5× 501 0.6× 288 0.5× 475 1.1× 310 1.0× 42 1.9k
J. Craig Nelson United States 21 1.3k 1.3× 1.1k 1.4× 425 0.8× 253 0.6× 239 0.8× 47 2.3k
Y.D. Lapierre Canada 27 560 0.6× 1.1k 1.4× 432 0.8× 408 0.9× 521 1.7× 139 2.6k
J. Craig Nelson United States 33 1.3k 1.4× 1.4k 1.8× 613 1.1× 431 1.0× 496 1.6× 87 3.2k

Countries citing papers authored by F M Quitkin

Since Specialization
Citations

This map shows the geographic impact of F M Quitkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F M Quitkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F M Quitkin more than expected).

Fields of papers citing papers by F M Quitkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F M Quitkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F M Quitkin. The network helps show where F M Quitkin may publish in the future.

Co-authorship network of co-authors of F M Quitkin

This figure shows the co-authorship network connecting the top 25 collaborators of F M Quitkin. A scholar is included among the top collaborators of F M Quitkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F M Quitkin. F M Quitkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agosti, Vito, F M Quitkin, Jonathan W. Stewart, & Patrick J. McGrath. (2002). Somatization as a predictor of medication discontinuation due to adverse events. International Clinical Psychopharmacology. 17(6). 311–314. 20 indexed citations
2.
McGrath, Patrick J., J W Stewart, Eva Petkova, et al.. (2000). Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression. The Journal of Clinical Psychiatry. 61(7). 518–524. 51 indexed citations
3.
Stewart, Jonathan W., F M Quitkin, Patrick J. McGrath, & Gerard E. Bruder. (1999). Do tricyclic responders have different brain laterality?. Journal of Abnormal Psychology. 108(4). 707–710. 13 indexed citations
4.
Bruder, Gerard E., Craig E. Tenke, Jonathan W. Stewart, Patrick J. McGrath, & F M Quitkin. (1999). Predictors of Therapeutic Response to Treatments for Depression: A Review of Electrophysiologic and Dichotic Listening Studies. CNS Spectrums. 4(8). 30–36. 8 indexed citations
5.
Michelson, David, Jay D. Amsterdam, F M Quitkin, et al.. (1999). Changes in Weight During a 1-Year Trial of Fluoxetine. American Journal of Psychiatry. 156(8). 1170–1176. 133 indexed citations
6.
Nunes, Edward V., F M Quitkin, Stephen J. Donovan, et al.. (1998). Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders. Archives of General Psychiatry. 55(2). 153–153. 127 indexed citations
7.
Quitkin, F M, Patrick J. McGrath, J W Stewart, et al.. (1998). Placebo run-in period in studies of depressive disorders. The British Journal of Psychiatry. 173(3). 242–248. 29 indexed citations
8.
Bruder, Gerard E., Regan Fong, Craig E. Tenke, et al.. (1997). Regional brain asymmetries in major depression with or without an anxiety disorder: A quantitative electroencephalographic study. Biological Psychiatry. 41(9). 939–948. 294 indexed citations
9.
Nunes, Edward V., Patrick J. McGrath, F M Quitkin, et al.. (1995). Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug and Alcohol Dependence. 39(3). 185–195. 76 indexed citations
10.
Nunes, Edward V., Stephen J. Donovan, Ronald Brady, & F M Quitkin. (1994). Evaluation and Treatment of Mood and Anxiety Disorders in Opioid-Dependent Patientst. Journal of Psychoactive Drugs. 26(2). 147–153. 19 indexed citations
11.
Otto, Michael W., et al.. (1994). Norms for depressed patients for the California verbal learning test: Associations with depression severity and self-report of cognitive difficulties. Archives of Clinical Neuropsychology. 9(1). 81–88. 42 indexed citations
12.
Stewart, J W, et al.. (1994). Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.. PubMed. 55(8). 336–9. 7 indexed citations
13.
Quitkin, F M. (1990). Atypical Depression, Panic Attacks, and Response to Imipramine and Phenelzine. Archives of General Psychiatry. 47(10). 935–935. 115 indexed citations
14.
Quitkin, F M, Patrick J. McGrath, J W Stewart, et al.. (1989). Phenelzine and Imipramine in Mood Reactive Depressives. Archives of General Psychiatry. 46(9). 787–787. 93 indexed citations
15.
Stewart, Jonathan W., Wilma Harrison, Thomas B. Cooper, & F M Quitkin. (1988). Tyramine Sulfate excretion may be a better predictor of antidepressant response than Monoamine Oxidase activity. Psychiatry Research. 25(2). 195–201. 7 indexed citations
16.
Quitkin, F M, et al.. (1988). Panic disorder and depression in female alcoholics.. PubMed. 49(11). 441–3. 28 indexed citations
17.
McGrath, Patrick J., Jonathan W. Stewart, Michael R. Liebowitz, et al.. (1988). Lactate provocation of panic attacks in depressed outpatients. Psychiatry Research. 25(1). 41–47. 21 indexed citations
18.
Quitkin, F M, et al.. (1981). Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings].. PubMed. 17(1). 136–8. 4 indexed citations
19.
Rifkin, Arthur & F M Quitkin. (1978). What's new in the psychopharmacology of schizophrenia.. PubMed. 54(9). 869–78. 1 indexed citations
20.
Quitkin, F M, Arthur Rifkin, & Klein Df. (1977). A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.. PubMed. 13(3). 27–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duane G. Spiker Breakdown of academic impact, for papers by Michael Philipp Breakdown of academic impact, for papers by J. Mendlewicz Breakdown of academic impact, for papers by Eric D. Peselow Breakdown of academic impact, for papers by Sanjay Dubé Breakdown of academic impact, for papers by M E Thase Breakdown of academic impact, for papers by J. E. Christie Breakdown of academic impact, for papers by J. Craig Nelson Breakdown of academic impact, for papers by Y.D. Lapierre Breakdown of academic impact, for papers by J. Craig Nelson
Rankless by CCL
2026